Lithuanian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 54 displayed.
1 2 3 »

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 23 May 2022

Novo Nordisk A/S: Share repurchase programme

Read more ››

By: GlobenewsWire - 16 May 2022

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››

By: GlobenewsWire - 11 May 2022

Novo Nordisk A/S:

Read more ››

By: GlobenewsWire - 06 May 2022

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››

By: GlobenewsWire - 06 May 2022

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››

By: GlobenewsWire - 03 May 2022

Novo Nordisk A/S purchases B shares worth DKK 3,402 million from Novo Holdings A/S under the 2022 share repurchase programme

Read more ››

By: GlobenewsWire - 03 May 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 03 May 2022

Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››

By: GlobenewsWire - 03 May 2022

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 29 April 2022

Read more ››

By: GlobenewsWire - 02 May 2022

Novo Nordisk – major shareholder announcement

Read more ››

By: GlobenewsWire - 02 May 2022

Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 29 April 2022

Read more ››

By: GlobenewsWire - 29 Apr 2022

Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022

Read more ››

By: GlobenewsWire - 29 Apr 2022

Once-weekly insulin icodec demonstrates superior reduction in HbA1c vs insulin degludec in people with type 2 diabetes in ONWARDS 2 phase 3a trial

Read more ››

By: GlobenewsWire - 28 Apr 2022

Novo Nordisk A/S – Reduction of the share capital

Read more ››

By: GlobenewsWire - 27 Apr 2022

Novo Nordisk A/S - Articles of Association

Read more ››

By: GlobenewsWire - 27 Apr 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 25 Apr 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 11 Apr 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 04 Apr 2022

Ozempic® 2.0 mg approved in the US for the treatment of type 2 diabetes

Read more ››

By: GlobenewsWire - 28 Mar 2022

Looking for companies outside of Lithuania?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

June 2022
- Digital RESI
- Product & Company Valuation Course
- BIO International Convention 2022

Add an Event »

Latest company news

Novo Nordisk A/S – Share repurchase programme
23 May 2022 (GlobenewsWire)

Novo Nordisk A/S: Share repurchase programme
16 May 2022 (GlobenewsWire)

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
11 May 2022 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Lithuanian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com